Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function.

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Cancer cachexia is a complex syndrome causing anorexia, weight loss, and muscle wasting.
• These symptoms significantly reduce cancer patients' quality of life and survival rates.

Purpose of the Study:

• To investigate the effects of modulating autophagy on cancer-induced muscle wasting.
• To assess the impact of autophagy inhibition (beclin-1 knockdown) and promotion (TP53INP2/DOR overexpression) on muscle mass and morphology in a mouse model.

Main Methods:

• Utilized C26 tumor-bearing mice to model cancer cachexia.
• Manipulated autophagy levels by knocking down beclin-1 and overexpressing TP53INP2/DOR.
• Administered formoterol, a selective β2-agonist, to assess its effects on muscle wasting and autophagy.
• Analyzed muscle morphology, mass, gene expression (atrogenes, mitochondrial dynamics), and ex vivo muscle fiber respiration.

Main Results:

• Autophagy inhibition failed to prevent muscle mass loss and worsened muscle morphology in tumor-bearing mice.
• Formoterol treatment preserved muscle mass, associated with reduced static autophagy markers but maintained flux.
• Stimulating muscle autophagy exacerbated muscle atrophy and promoted atrogene expression.
• Overexpression of TP53INP2 suppressed mitochondrial dynamics genes, suggesting impaired mitochondrial function via mitophagy.
• Reduced ex vivo muscle fiber respiration indicated tumor-induced mitochondrial dysfunction.

Conclusions:

• Muscle autophagy plays a critical role in the development of cancer-induced muscle wasting.
• Excessive autophagy may impair mitochondrial function, contributing to muscle atrophy.
• Modulating autophagy, particularly excessive stimulation, could be a therapeutic target for cancer cachexia.